| 1 | 93470-21-4 | Cyclohexane, 1-ethoxy-4-(isocyanatomethyl)-2-methoxy- (9CI) | C11H19NO3 | 213.27346 | | |
| 2 | 93470-26-9 | (R)-1-CYCLOHEXYLETHYL ISOCYANATE | C9H15NO | 153.22 | | |
| 3 | 93470-27-0 | (S)-(+)-1-Cyclohexylethyl Isocyanate | C9H15NO | 153.23 | | |
| 4 | 93470-31-6 | 1-(2-Hydroxy-julolidin-4-yl)-3-(1,4-dihydro-2-hydroxy-julolidin-4-ylidene-onium)-2-oxo-cyclobuten-4-olate | C28H28N2O4 | 456.539 | | |
| 5 | 934701-03-8 | Cynancersicoside C | C28H40O10 | 536.6112 | | |
| 6 | 934703-71-6 | TPT1 , N4,N4'-(biphenyl-4,4'-diyl)bis(N4,N4',N4'-triphenylbip | C72H54N4 | 975.23 | | |
| 7 | 934703-72-7 | [1,1'-Biphenyl]-3,4'-diaMine, N3,N4'-bis[4'-(diphenylaMino)[1,1'-biphenyl]-4-yl]-N3,N4'-diphenyl- | C72H54N4 | 975.23 | | |
| 8 | 934703-94-3 | 2,6-dimethyl-4-morpholinecarbonyl chloride | C7H12ClNO2 | 177.63 | | |
| 9 | 934705-15-4 | URETHANE DIMETHACRYLATE | C9H11NO4 | 197.19 | | |
| 10 | 934705-43-8 | 3,4-a']dinaphthalen-4-yl)[(1R)-1-phenylethyl]-aMine | C28H22NO2P | 435.453541 | | |
| 11 | 934705-57-4 | Benzoic acid, 2-methyl-6-(trifluoromethyl)-, methyl ester | C10H9F3O2 | 218.17 | | |
| 12 | 934705-79-0 | methyl 2-(3-methoxy-2-nitrophenyl)acetate | C10H11NO5 | 225.2 | | |
| 13 | 934708-59-5 | Acetamide, N-(6-amino-3-cyano-4-methyl-2-pyridinyl)- | C9H10N4O | | | |
| 14 | 934708-86-8 | 1,3,5-Tris(4-aMino-2-(trifluoroMethyl)phenoxy)benzene | C27H18F9N3O3 | 603.4357488 | | |
| 15 | 934709-48-5 | Benzeneacetic acid, 3-bromo-5-nitro- | C8H6BrNO4 | 260.04 | | |
| 16 | 934709-49-6 | Benzeneacetic acid, 3-bromo-5-nitro-, methyl ester | C9H8BrNO4 | 274.07 | | |
| 17 | 93471-41-1 | Dimethylpyridinium P-Toluenesulfonate | C14H17NO3S | 279.35 | 117 °C | almost transparency |
| 18 | 934714-22-4 | ARP100 | | | | |
| 19 | 934714-36-0 | Esomeprazole Strontium | C17H23N3O4SSr | 453.07 | | |
| 20 | 93472-34-5 | Benzothiazole, 2-(4-methyl-2-oxazolyl)- (9CI) | C11H8N2OS | 216.25902 | | |
| 21 | 93472-35-6 | Quinoline, 2-(2-thiazolyl)- | C12H8N2S | 212.27 | | |
| 22 | 93472-59-4 | Silane, tris[(1,1-dimethyl-2-propynyl)oxy]phenyl- | C21H26O3Si | 354.51 | | |
| 23 | 93472-93-6 | Carbamic acid, (3-mercaptopropyl)-, 1,1-dimethylethyl ester (9CI) | C8H17NO2S | 191.29 | | |
| 24 | 934738-25-7 | (5-fluoro-2-hydroxybenzyl)(triphenyl)phosphonium bromide | C25H21BrFOP | 467.32 | | |
| 25 | 934739-29-4 | Karavilagenin D | C30H46O4 | 470.68384 | | |
| 26 | 934739-32-9 | Karaviloside VIII | C36H58O9 | 634.85 | | |
| 27 | 934739-34-1 | Karaviloside X | C42H68O14 | 796.99 | | |
| 28 | 934739-35-2 | Karaviloside XI | C36H60O10 | 652.87 | | |
| 29 | 93474-11-4 | (5aS)-5,5aα,6,7,8,9,9a,9b-Octahydro-6,6,9aβ-trimethyl-9bα-methoxynaphtho[1,2-b]furan-2(4H)-one | C16H24O3 | 264.35996 | | |
| 30 | 93474-52-3 | 2,3,3-trimethylpiperidine | C8H17N | 127.23 | | |
| 31 | 934740-23-5 | Nifeviroc Impurity 33 | | | | |
| 32 | 934740-24-6 | Nifeviroc Impurity 30 | | | | |
| 33 | 934740-25-7 | Carbamic acid, N-[1-[[(3R,4S)-1-(cyclopentylcarbonyl)-4-hydroxy-4-phenyl-3-pyrrolidinyl]methyl]-4-piperidinyl]-N-2-propen-1-yl-, (4-nitrophenyl)methyl ester, rel- | C33H42N4O6 | 590.71 | | |
| 34 | 934740-26-8 | Nifeviroc Impurity 5 | | | | |
| 35 | 934740-27-9 | Nifeviroc Impurity 46 | | | | |
| 36 | 934740-29-1 | Nifeviroc Impurity 26 | | | | |
| 37 | 934740-30-4 | Nifeviroc Impurity 42 | | | | |
| 38 | 934740-33-7 | Nifeviroc | C33H42N4O6 | 590.71 | | |
| 39 | 934740-36-0 | Nifeviroc Impurity 38 | | | | |
| 40 | 934740-37-1 | Nifeviroc Impurity 24 | | | | |
| 41 | 934740-42-8 | 3-Pyrrolidinecarboxylic acid, 4-hydroxy-5-oxo-4-phenyl-1-[(1R)-1-phenylethyl]-, (3S,4R)- | C19H19NO4 | 325.36 | | |
| 42 | 934740-43-9 | 1-[[(3S,4R)-4-Hydroxy-5-oxo-4-phenyl-1-[(1R)-1-phenylethyl]-3-pyrrolidinyl]carbonyl]-4-piperidinone | C24H26N2O4 | 406.48 | | |
| 43 | 934740-48-4 | Methanone, cyclopentyl[(3R,4S)-3-hydroxy-3-phenyl-4-[[4-(2-propen-1-ylamino)-1-piperidinyl]methyl]-1-pyrrolidinyl]- | C25H37N3O2 | 411.58 | | |
| 44 | 934743-41-6 | 5-aMino-3-tert-butyl-1H-pyrazole-4-carbonitrile | C8H12N4 | 164.20768 | | |
| 45 | 934744-59-9 | 3-(2-Hydroxy-ethoxyMethyl)-piperidine-1-carboxylic acid benzyl ester | C16H23NO4 | 293.36 | | |
| 46 | 934744-61-3 | 3-(2-AMino-ethoxyMethyl)-piperidine-1-carboxylic acid benzyl ester | C16H24N2O3 | 292.37 | | |
| 47 | 934745-61-6 | N-Boc-(S)-3-(piperidin-3-ylmethoxy)propanoic acid | C14H25NO5 | 287.36 | | |
| 48 | 934747-29-2 | 3-Pyridinecarbonitrile, 1,2-dihydro-6-hydroxy-1,4-dimethyl-5-[2-[4-[(methylsulfonyl)oxy]phenyl]diazenyl]-2-oxo- | C15H14N4O5S | | | |
| 49 | 934747-31-6 | 3-Pyridinecarbonitrile, 5-[2-[4-(4-chlorobenzoyl)phenyl]diazenyl]-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo- | C21H15ClN4O3 | | | |
| 50 | 93475-15-1 | Benzenesulfonamide, N-(2-hydroxybicyclo[2.2.1]hept-7-yl)- | C13H17NO3S | 267.34 | | |
| 51 | 93475-27-5 | (4-METHOXY-PHENYL)-MORPHOLIN-4-YL-ACETIC ACID HYDROCHLORIDE | C13H18ClNO4 | 287.74 | | |
| 52 | 93475-38-8 | DIETHYL 6-ETHOXY-2-OXO-1,2-DIHYDRO-3,5-PYRIDINEDICARBOXYLATE | C13H17NO6 | 283.28 | | |
| 53 | 93475-44-6 | Oxolamine Impurity 85 | | | | |
| 54 | 93475-45-7 | Oxolamine Impurity 116 | | | | |
| 55 | 93475-46-8 | Oxolamine Impurity 115 | | | | |
| 56 | 93475-47-9 | Oxolamine Impurity 21 | | | | |
| 57 | 93475-86-6 | 4-Pyrimidinepropanoicacid, 2,6-diethoxy-5-nitro-a-oxo-, ethyl ester | C13H17N3O7 | 327.28998 | | |
| 58 | 93475-98-0 | Pseudourea,3,3-dibutyl-2-(2-methylallyl)- (7CI) | C13H26N2O | 226.35834 | | |
| 59 | 934750-84-2 | 1H-Indole-3-carboxylic acid, 2-(2-carboxyethenyl)- | C12H9NO4 | 231.2 | | |
| 60 | 934752-37-1 | Glycine, N-[8-[[(1,1-dimethylethoxy)carbonyl]amino]octyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]- | C30H40N2O6 | 524.65 | | |
| 61 | 934757-43-4 | Tert-butyl (2-((4-(trifluoroMethoxy)benzyl)aMino)ethyl)carbaMate | C15H21F3N2O3 | 334.3340496 | | |
| 62 | 934757-53-6 | 1H-Indene-1-carboxylic acid, 6-(chlorosulfonyl)-2,3-dihydro-, methyl ester | C11H11ClO4S | 274.72 | | |
| 63 | 934758-27-7 | 2-Amino-6-bromo-3-pyridinol | C5H5BrN2O | 189.01 | | |
| 64 | 934758-70-0 | BLX3887 | C10H5Cl3FN3O | 308.52 | | |
| 65 | 934758-92-6 | 5-chloro-1H-pyrazole | C3H3ClN2 | 102.52232 | | |
| 66 | 934758-94-8 | Ethyl 4-(trifluoromethyl)-1H-pyrazole-3-carboxylate | C7H7F3N2O2 | 208.14 | | |
| 67 | 934758-97-1 | 4-BROMO-4'-METHOXY-2'-METHYLBIPHENYL | C14H13BrO | 277.16 | | |
| 68 | 934759-08-7 | 4-Bromo-4'-methoxy-2-methyl-1,1'-biphenyl | C14H13BrO | 277.16 | | |
| 69 | 934759-09-8 | 3-Difluoromethyl-5-Methyl-1H-Pyrazole | C5H6F2N2 | 132.11 | | |
| 70 | 93476-40-5 | (2-M-TOLYL-THIAZOL-4-YL)-METHANOL | C11H11NOS | 205.28 | | |
| 71 | 93476-41-6 | 3-Hydroxy-1,4-diMethylquinolin-2(1H)-one | C11H11NO2 | 189.21 | | |
| 72 | 93476-46-1 | Ethyl indolizine-1-carboxylate | C11H11NO2 | 189.21 | | |
| 73 | 93476-51-8 | 1-(3-methylphenyl)-2,5-pyrrolidinedione | C11H11NO2 | 189.21 | | |
| 74 | 93476-60-9 | 5-Ethoxy-1H-indole-2-carboxylic acid | C11H11NO3 | 205.21 | 179 °C | |
| 75 | 934760-90-4 | Compound KD3010 TOSYLATE | C23H25F3N2O5S.C7H8O3S | 670.72 | | |
| 76 | 934760-92-6 | KD-3010 | C30H33F3N2O8S2 | 670.72 | | |
| 77 | 934760-93-7 | Cis-3,5-dimethyl-1-(4-(trifluoromethoxy)phenyl)piperazine hydrochloride | C13H18ClF3N2O | 310.75 | | |
| 78 | 934762-26-2 | 7-Bromo-9,9-dihexylfluoren-2-yl-boronicacid | C25H34BBrO2 | 457.25 | | |
| 79 | 934762-68-2 | (r)-n-((1r,2r)-2-(3-(3,5-bis(trifluoromethyl)phenyl)ureido)cyclohexyl)-2-methylpropane-2-sulfinamide | C19H25F6N3O2S | 473.48 | 173-181°C | |
| 80 | 934763-10-7 | GSK-982 | C22H27N3O | 349.46928 | | |
| 81 | 934765-76-1 | Carbamic acid, N-(5-cyano-2,3-dihydro-1H-inden-2-yl)-, 1,1-dimethylethyl ester | C15H18N2O2 | 258.32 | | |
| 82 | 934765-86-3 | Carbamic acid, N-[(1S)-3,3-dimethylcyclohexyl]-, phenylmethyl ester | C16H23NO2 | 261.36 | | |
| 83 | 934765-87-4 | Phenylmethyl N-[(1R)-3,3-dimethylcyclohexyl]carbamate | C16H23NO2 | 261.36 | | |
| 84 | 934765-88-5 | (S)-3,3-dimethylcyclohexan-1-amine hydrochloride | C8H18ClN | 163.68822 | | |
| 85 | 934765-89-6 | (R)-3,3-dimethylcyclohexan-1-amine hydrochloride | C8H18ClN | 163.68822 | | |
| 86 | 934767-42-7 | 4-Iodo-1-methyl-1H-indole | C9H8IN | 257.07 | | |
| 87 | 934768-05-5 | Polygalin C | C28H32O16 | 624.55 | | |
| 88 | 93477-14-6 | 9H-Purin-2-amine, 9-butyl-6-[(4-pyridinylmethyl)thio]- | C15H18N6S | 314.41 | | |
| 89 | 93477-23-7 | Dimemorfan Impurity 24 | | | | |
| 90 | 93477-35-1 | (+/-)-1-(4-methoxybenzyl)-1,2,3,4,5,6,7,8-octahydroisoquinoline hydrobromide | | | 198-199 °C | |
| 91 | 93477-40-8 | 1(2H)-Naphthalenone, 3,4-dihydro-3-methyl-2-(1-piperidinylmethyl)-, hydrochloride (1:1) | C17H24ClNO | 293.84 | | |
| 92 | 93477-51-1 | Dimemorfan Impurity 67 | | | | |
| 93 | 93477-80-6 | 1-Naphthalenol, decahydro-, 1-(N-phenylcarbamate) | C17H23NO2 | 273.37 | | |
| 94 | 93478-48-9 | 1-benzyl-pyrrolidine-2,5-dicarboxylic acid diethyl ester(HCl) | C17H23NO4 | 305.37 | | |
| 95 | 93478-72-9 | methyl 4-(dicyclohexylamino)butanoate | C17H31NO2 | 281.43 | | |
| 96 | 93479-03-9 | Butanamide, N-[4-(2-butoxyethyl)-3-methyl-5-isoxazolyl]-2-(dimethylamino)-3-methyl- | C17H31N3O3 | 325.45 | | |
| 97 | 93479-06-2 | Propanamide, N-[4-(2-butoxyethyl)-3-methyl-5-isoxazolyl]-2-(diethylamino)- | C17H31N3O3 | 325.45 | | |
| 98 | 93479-22-2 | Pseudourea, 2-(2-ethylhexyl)-3,3-bis(2-methylallyl)- (7CI) | C17H32N2O | 280.45 | | |
| 99 | 93479-23-3 | Acetamide, N,N-diethyl-2-[(3-hydroxy-4,7,7-trimethylbicyclo[2.2.1]hept-2-yl)methylamino]- | C17H32N2O2 | | | |
| 100 | 93479-48-2 | decyl cyclohexanecarboxylate | C17H32O2 | 268.43478 | | |
| 101 | 93479-66-4 | 5-Oxoheptadecanoic acid | C17H32O3 | 284.43 | | |
| 102 | 93479-67-5 | Heptadecanoic acid, 6-oxo- | C17H32O3 | 284.43 | | |
| 103 | 93479-68-6 | Heptadecanoic acid, 7-oxo- | C17H32O3 | 284.43 | | |
| 104 | 93479-69-7 | Heptadecanoic acid, 16-oxo- | C17H32O3 | 284.43 | | |
| 105 | 93479-96-0 | Alteconazole | C17H12Cl3N3O | 380.65568 | | |
| 106 | 93479-97-1 | Glimepiride | C24H34N4O5S | 490.62 | 212.2-214.5 °C | DMSO: >10 mg/mL |